How hydroxychloroquine went from a tweeted Google Doc to Trump's favorite COVID-19 drug


Everyone wants a cure for COVID-19, the new coronavirus spreading around the world and causing economic and social upheaval. An effective treatment would also go a long way toward helping the world amble toward normalcy while researchers develop and test a vaccine. President Trump has put great store in hydroxychloroquine, a malaria drug used now to treat lupus and rheumatoid arthritis, but his federal health and medical advisers are skeptical.
The idea of the drug as a potential COVID-19 treatment started with Chinese reports of clinical trials, a tweet from Nigeria, and Facebook posts from France, Washington Post fact-checker Elyse Samuels recounts, but it started taking off in the U.S. when a block-chain investor tweeted a Google Doc he co-wrote exploring chloroquine's coronavirus-slaying properties — and Elon Musk retweeted it three days later, on March 16. Conservative media picked up the claims, then Fox News, and finally Trump and his close allies.
"As hype around the drugs continued, experts were wary about a lack of scientific evidence," with Dr. Anthony Fauci repeatedly noting there was nothing but "anecdotal reports" backing up the drug's claims, Samuels noted, explaining: "Anecdotal evidence is like a Yelp review, but for science." Trump argues that coronavirus patients have nothing to lose, but "there have been and will continue to be negative consequences of overpromising the drug's potential," she added. "Rumors on the internet are the least reliable source of information, and politicians are not qualified to give scientific advice, despite even the best of intentions." Watch Samuels' brief history of a would-be miracle cure, and her conversations with experts on why it probably isn't, below. Peter Weber
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Trump uses tariffs to upend Brazil's domestic politics
IN THE SPOTLIGHT By slapping a 50% tariff on Brazil for its criminal investigation into Bolsonaro, the Trump administration is brazenly putting its fingers on the scales of a key foreign election
-
3 questions to ask when deciding whether to repair or replace your broken appliance
the explainer There may be merit to fixing what you already have, but sometimes buying new is even more cost-effective
-
'Trump's authoritarian manipulation of language'
Instant Opinion Vienna has become a 'convenient target for populists' | Opinion, comment and editorials of the day
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths